Stryker’s research in additive manufacturing began in 2001. Focusing on innovation, design freedom, and improving healthcare, Stryker’s Tritanium® technology has been used in several FDA-cleared orthopedic implants. This allows for effective and consistent creation of porous structures. The design freedom empowered by AM allows porous structures to be applied to new areas of an implant that was previously impossible. Dr. Murray will share her experiences highlighting how AMagine, Stryker’s proprietary approach to implant creation using additive manufacturing has made possible revolutionary design freedom. She will also share her experiences about how additive manufacturing can be used in many situations from prototyping to product manufacturing.